Week 1: Pathogenesis of Diabetes Mellitus Flashcards

1
Q

Normal regulation of blood sugar

A
  1. Insulin lowers blood glucose via:
    - suppression of hepatic glucose production
    - stimulation of glucose utilization by tissues w/ GLUT4: skeletal muscle, adipose tissue, cardiac muscle
  2. Insulin sensitivity varies among normal people
    - white males have greatest sensitivity
    - puberty, obese, 3rd trimester pregnancy have low insulin sensitivity
  3. B cell function varies according to body’s insulin needs
    - insulin resistant people have to make a lot more insulin
    - if don’t make enough insulin than needed, will have diabetes
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Regulation of insulin secretion on cellular level

A
  • glucose enters via high capacity GLUT2 transporter in beta cell. metabolized via high capacity glucokinase to ATP
  • ATP shuts down outward rectifying K+ channel, which holds cell hyper polarized at -90mV. Shutting down the channel makes cell less negative and depolarizes at -60mV
  • depolarization release insulin
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Insulin signaling and stimulation of glucose uptake: cellular level

A
  • insulin binds to receptor on cell membrane, causes autophosphorylation of receptor
  • phosphorylated insulin receptor acts as a kinase to stimulate phosphorylation of IRS1 and IRS2 (signaling molecules in cytoplasm)
  • activated IRS1 and 2 stimulate production of PI-3-kinase, which through unknown ways, stimulates intracellular vesicles containing GLUT4 to move to cell surface
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Diagnosis of Diabetes mellitus

A

One of the following

  1. elevated blood glucose level with symptoms of hyperglycemia
  2. fasting serum or plasma glucose>126 mg/dl
  3. 2 hour glucose level>200mg/dl during 75 g oral glucose tolerance test
  4. HbA1C>6.5%
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Classification of Type 1 vs Type 2 DM

A
  • Type 1: hyperglycemia due to severe or absolute insulin deficiency. Beta cell defect alone
  • Type 2: hyperglycemia due to insulin resistance with relative insulin deficiency. Beta cell defect with insulin resistance.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Clinical characteristics of Type 1 DM

A
  • inherited susceptibility: HLA gene important, but not only genes involved
  • acute onset of symptoms
  • recent viral illness common
  • immune markers present at onset: circulating evidence for antibodies directed against beta cell antigens
  • “honeymoon” period
  • most common in children/teens and people of european descent
  • can develop DKA
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Pathogenesis of Type 1 diabetes

A
  • first have genetic risk
  • precipitating event: believed to be virus associated
  • immune markers appear, beta cell mass starts to decrease
  • insulin response reduced
  • glucose is elevated
  • then insulin becomes absent as beta cell mass decreases to nothing
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Rx for Type 1 DM

A
  • Secondary therapy (insulin replacement: exogenous insulin. Pancreas transplant and islet transplant are temporary
  • primary therapy: has not worked using immunosuppressive drugs
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Characteristics of type 2 DM

A
  • some, often great, degree of resistance to their own insulin
  • many causes of insulin resistance: obesity most common. lipid reduces insulin action on glucose uptake in muscle and glucose production in liver
  • relative insulin deficiency compared to increased needs
  • make some insulin, rarely develop DKA
  • more than 90% of DM is Type 2. Most common in ppl of African, Native American, Asian origin.
  • gradual onset: normal to impaired glucose tolerance to overt diabetes
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

intracellular mechanisms for insulin resistance

A
  • fatty acids and inflammatory cytokines such as TNF-a cause chronic phosphorylation via phosphokinase C of molecules in the insulin signaling cascade (IRS1 and 2) at the wrong place (serine and threonine)
  • these block activating phosphorylations on tyrosine that normally mediate insulin signaling
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Pancreatic b-cell defect in DM Type 2

A

progressive beta cell defect may be caused by

  1. beta cell exhaustion early on
  2. rising glucose levels, toxic effects of chronic hyperglycemia
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Hepatic glucose overproduction in DM type 2

A
  1. fasting hyperglycemia due to increased production of glucose by the liver
  2. mainly results from gluconeogenesis than glycogen breakdown
  3. liver in overt diabetes is resistant to glucose and insulin
  4. mechanisms not completely known. May be due to increase FFA delivery to the liver
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Summary of causes of hyperglycemia in Type 2 DM

A
  1. insulin resistance
  2. pancreatic beta cell defect
  3. hepatic glucose overproduction
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

visceral fat and insulin resistance

A
  • visceral fat has more insulin resistance than subcutaneous adiposity. visceral fat may be better at releasing FFA
  • people with the highest central abdominal fat had lowest insulin sensitivity
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Hormonal products of adipose tissue

A
  1. increase with obesity, block insulin action
    - leptin, TNF-a, Il-6, Resistan
  2. decreases with obesity, enhances insulin action
    - adiponectin: found more in small skinny fat cells
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Reversal of glucose toxicity in T2DM

A
  • elevated glucose levels contribute to insulin resistance and may impair pancreatic b cell function
  • treat aggressively, short term 1-2 month Rx with insulin or oral anti-diabetic drugs to normalize blood glucose can improve insulin action and secretion
  • insulin requirements feel with decreased glucose levels, however patients remain considerably insulin resistant after Rx
17
Q

Strategies for treating type 2 DM

A
  1. reduce insulin resistance
    - lifestyle: weight loss and exercise
    - thiazolidinedione drugs
    - metformin: reduces hepatic glucose production, acts like insulin sensitizer
  2. increase insulin levels
    - sulfonylurea: augment insulin secretion at ATP sensitive K+ channel
    - glinide drugs: same as above
    - incretin analogs
    - DDP4 inhibitors
  3. slow glucose absorption from gut
    - acarbose: slows digestion of starches
    - pramlintide: slow GI motility
18
Q

Opportunities for prevention in T2DM

A
  • treat people who have impaired insulin secretion, with slightly elevated glucose levels
  • weight loss, TZDs to decrease insulin resistance, metformin to deal with hyperglycemia